WCM
CLBT icon

Wisconsin Capital Management’s Cellebrite CLBT Stock Holding History

Wisconsin Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-89,000
Closed -$1.6M – 54
2025
Q4 		$1.6M Hold
89,000
– – 0.81% 31
2025
Q3 		$1.65M Buy
+89,000
New +$1.4M 0.84% 31

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wisconsin Capital Management's CLBT Position: Q1 2026 in Review

Wisconsin Capital Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 89,000 shares — an estimated $1.6M sold.

Wisconsin Capital Management first reported a position in CLBT in Q3 2025 and held it in 2 quarters. The position peaked at $1.65M in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Wisconsin Capital Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Wisconsin Capital Management sold 89,000 Cellebrite shares in Q1 2026, an estimated $1.6M.
  • Wisconsin Capital Management first reported a position in Cellebrite in Q3 2025 and held it in 2 quarters.
  • Wisconsin Capital Management's Cellebrite position peaked at $1.65M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Wisconsin Capital Management's 13F filing for Q1 2026, filed 12 May 2026.